ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014

ASCO Report Urges 5% Annual Increase For NIH.

December 8, 2006

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

In Brief: GM Cancer Research Foundation Awards Three Prizes to Five Cancer Researchers

May 5, 2000

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

November 5, 1999